 The greatest contribution Roche
can make to society is to continue developing innovative medicines and diagnostics
that respond to medical
needs, as well as save and improve quality of life. But for many reasons,
not everyone has equal access to healthcare. Some patients are able to live longer, healthier lives
than others with the same disease because the same level of medical care is not available in all countries
– often because of cost or lack of infrastructure.
The development and
improvement in the provision of healthcare is the responsibility of governments, however, the healthcare
sector can contribute through a number of mechanisms. Healthcare resources and needs vary widely from
country to country and cannot be provided for with a single approach. Roche has developed different
strategies and programmes for improving global access, reflecting the needs of the different regions
and providing benefits to the country.
In the world’s poorest countries,
there is a critical lack of even the most basic healthcare. This makes treating serious diseases such
as HIV/AIDS, malaria and tuberculosis an enormous challenge. We work in partnership with governments
and local partners to provide sustainable healthcare for the people most affected by disease, by:
Even
in the developed world, access for patients to innovative medicines varies between countries. This is
due to many factors, such as lack of reimbursement of these products, public health funding failing
to keep pace with the burden of the disease, lack of payment by insurance companies, through to lack
of medical insurance in general. We support a number of initiatives that help provide
healthcare to
those in need.
In addition,
we
work closely with governments and payers to demonstrate the value of our products and
services to patients,
society and healthcare systems.
Click here for
a summary table of all our access programmes.
Preparing
for the Next Pandemic Influenza - Roles and Responsibilities of Roche |
 |
print this page